Literature DB >> 1823875

Metabolism of cannabidiol by the rat.

E Samara1, M Bialer, D J Harvey.   

Abstract

Metabolites of CBD excreted into the bile and perfusion fluid were examined in a rat liver perfusion preparation. Metabolites were extracted with ethyl acetate and identified by GC/MS as TMS derivatives. Four mono- and five di-hydroxy metabolites were identified with major sites of metabolic attack being at C-7 and C-4". A hydroxy-ketone was detected but not fully identified. All biliary metabolites were conjugated with glucuronic acid. Urinary metabolites were studied in rats with samples taken at times to 25 h after drug administration. Unmetabolized CBD and 13 metabolites were identified by GC/MS. Major metabolites were acids with beta-oxidation being a prominent pathway. The 6- and 7-hydroxy derivatives of 4",5"-bis,nor-CBD-3"-oic acid were the most abundant compounds but substantial concentrations of the di-acids, CBD-5",7-dioic acid and 4",5"-bis,nor-CBD-3",7-dioic acid were present. Concentrations of the more highly oxidized metabolites increased with time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1823875     DOI: 10.1007/BF03189976

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

Review 1.  Structure-activity relationships in cannabinoids.

Authors:  R K Razdan
Journal:  Pharmacol Rev       Date:  1986-06       Impact factor: 25.468

2.  Identification of glucose conjugates as major urinary metabolites of cannabidiol in the dog.

Authors:  E Samara; M Bialer; D J Harvey
Journal:  Xenobiotica       Date:  1990-02       Impact factor: 1.908

3.  Identification of monohydroxylated metabolites of cannabidiol formed by rat liver.

Authors:  B Martin; M Nordqvist; S Agurell; J E Lindgren; K Leander; M Binder
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

4.  [Identification of potential cannalis containing substance metabolites: nuclear resonance and mass spectroscopic studies on side chain hydroxylation of cannabinoids].

Authors:  M Binder; S Agurell; K Leander; J E Lindgren
Journal:  Helv Chim Acta       Date:  1974       Impact factor: 2.164

5.  Isolated perfused rat liver technique.

Authors:  D K Meijer; K Keulemans; G J Mulder
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Dioxygenated metabolites of cannabidiol formed by rat liver.

Authors:  B Martin; S Agurell; M Nordqvist; J E Lindgren
Journal:  J Pharm Pharmacol       Date:  1976-08       Impact factor: 3.765

7.  Biotransformation of cannabidiol in mice. Identification of new acid metabolites.

Authors:  B R Martin; D J Harvey; W D Paton
Journal:  Drug Metab Dispos       Date:  1977 May-Jun       Impact factor: 3.922

8.  Metabolites of cannabidiol identified in human urine.

Authors:  D J Harvey; R Mechoulam
Journal:  Xenobiotica       Date:  1990-03       Impact factor: 1.908

9.  Identification of urinary metabolites of cannabidiol in the dog.

Authors:  E Samara; M Bialer; D J Harvey
Journal:  Drug Metab Dispos       Date:  1990 Sep-Oct       Impact factor: 3.922

10.  Identification of in vivo liver metabolites of delta 1-tetra-hydrocannabinol, cannabidiol, and cannabinol produced by the guninea-pig.

Authors:  D J Harvey; B R Martin; W D Paton
Journal:  J Pharm Pharmacol       Date:  1980-04       Impact factor: 3.765

View more
  2 in total

1.  Development of a Novel Nano-emulsion Formulation to Improve Intestinal Absorption of Cannabidiol.

Authors:  Yukako Nakano; Masataka Tajima; Erika Sugiyama; Vilasinee Hirunpanich Sato; Hitoshi Sato
Journal:  Med Cannabis Cannabinoids       Date:  2019-04-04

2.  Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol.

Authors:  Gabriela P Silote; Michelle C Gatto; Amanda Eskelund; Francisco S Guimarães; Gregers Wegener; Sâmia R L Joca
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.